abstract |
Compounds of formula: <CHEM> and pharmaceutically acceptable salts thereof, wherein R<1> is H; C1-C3 alkyl optionally substituted with one or more fluoro substituents; or C3-C5 cycloalkyl; R<2> is H, or C1-C6 alkyl optionally susbtituted with one or more fluoro subtituents or with C3-C6 cycloalkyl; R<3> is C1-C6 alkyl optionally substituted with one or more fluoro substituents or with C3-C6 cycloalkyl; C3-C5 cycloalkyl; C3-C6 alkenyl; or C3-C6 alkynyl; R<4> is C1-C4 alkyl optionally substituted with OH, NR<5>R<6>, CN, CONR<5>R<6> or CO2R<7>; C2-C4 alkenyl optionally substituted with CN, CONR<5>R<6> or CO2R<7>; C2-C4 alkanoyl optionally substituted with NR<5>R<6>; hydroxy C2-C4 alkyl optionally susbtituted with NR<5>R<6>; (C2-C3 alkoxy)C1-C2 alkyl optionally substituted with OH or NR<5>R<6>; CONR<5>R<6>; CO2R<7>; halo; NR<5>R<6>; NHSO2NR<5>R<6>; NHSO2R<8>; or phenyl or heterocyclyl either of which is optionally substituted with methyl; R<5> and R<6> are each independently H or C1-C4 alkyl, or together with the nitrogen atom to which they are attached from a pyrrolidinyl, piperidino, morpholino, 4-(NR<9>)-piperazinyl or imidazoyl group wherein said group is optionally substituted with methyl or hydroxy; R<7> is H or C1-C4 alkyl; R<8> is C1-C3 alkyl optionally substituted with NR<5>R<6>; and R<9> is H; C1-C3 alkyl optionally substituted with phenyl; hydroxy C2-C3 alkyl; or C1-C4 alkanoyl; are selective cGMP PDE inhibitors useful in the treatment of cardiovascular disorders such as angina, hypertension, heart failure and atherosclerosis. |